JaneSHankinsMD

PubMed

• Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease.
  Jennifer Longoria, Andrew Heitzer, Jane Hankins
  Pediatric Blood & Cancer. 2025-01-01
• Social determinants of health affect disease severity among preschool children with sickle cell disease.
  Hamda Khan, Guolian Kang, Jerlym S Porter, Juan Ding, Winfred C Wang
  Blood Advances. 2024-12-10
• Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Ce...
  Jennifer N Longoria, Kristen E Howell, Jerlym S Porter, Marsha Treadwell, Allison A King
  British Journal of Haematology. 2024-11-20

Journal Articles

• Ventricular Global Longitudinal Strain Is Altered in Children with Sickle Cell Disease  
  Vijaya M Joshi, Jane S Hankins, Ronak J Naik, British Journal of Haematology
• The clinical severity of hemoglobin S/black (A0-THALASSEMIA  
  Cancio MI, Aygun, B, Chui DHK, Rothman JA, Scot JP, Estepp JH, Hankins JS, Pediatric Blood and Cancer, 1/28/2017
• Radial UTE Imaging Removes the Need for Breath-holding in Hepatic Iron Overload Quantification by R2*-MRI  
  Tipirneni-Sajja A, Krafft AJ, McCarville MB, Loeffler RB, Song R, PhD, Hankins JS, Hillenbrand CM, Magn Reson Med, 1/16/2017
• The impact of the UGT1A1*60 allele on bilirubin serum concentrations  
  Pasternak AL, Crews KR, Caudle KE, Smith C, Pei D, Cheng C, Broeckel U, Gaur AH, Hankins JS, Relling MV, Haidar CE, Pharmacogenomics, 1/1/2017
• Can Multi-slice or Navigator-gated R2*-MRI Replace Single-slice Breath-hold Acquisition for Hepatic Iron Quantification?  
  Loeffler RB, McCarville MB, Wagstaff AW, Smeltzer MP, Krafft AJ, Song R, Hankins JS, Hillenbrand CM, Pediatr Radiol, 1/1/2017
• Barriers and Facilitators to Research Participation Among Adults and Parents of Children with Sickle Cell Disease: A Trans-regional Survey  
  Cronin RM, Hankins JS, Adams-Graves P, Thompson AA, Kalinyak K, Byrd J, McClain B, Kassim A, DeBaun M, Treadwell M, Am J Hematol, 1/1/2016
• Hydroxyurea Treatment and Brain MRI/MRA Findings in Children with Sickle Cell Anaemia  
  Nottage KA, Ware RE, Aygun B, Smeltzer MP, Kang G, Moen J, Wang WC, Hankins JS, and Helton KJ, Br J Haematol, 1/1/2016
• Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial  
  Wood JC, Cohen AR, Pressel SL, Aygun B, Imran H, Luchtman-Jones L, Thompson AA, Fuh B, Schultz WH, Davis BR, Ware RE; TWiTCH Investigators, Br J Haematol, 1/1/2016
• Does Fat Suppression via Chemically Selective Saturation (CHESS) Affect R2*-MRI for Transfusional Iron Overload Assessment? A Clinical Evaluation at 15 and 3 Tesla  
  Krafft A, Loeffler R, Song R, Brian X, McCarville M, Hankins J, Hillenbrand C, Magn Reson Med, 1/26/2015
• Prevalence of vitamin D deficiency in sickle cell disease: A systematic review  
  Nolan VG, Nottage KA, Cole EW, Hankins JS, Gurney JG, PLoS One., 1/3/2015
• Comparing segmented ASL perfusion of vascular territories using manual vs semi-automated techniques in children with sickle cell anemia  
  Glass J, Reddick G, Paydar A, Zandieh AR, Dave R, Smeltzer M, Wu S, Hankins JS, Aygun B, Ogg R, Helton K, J Magn Reson Imaging, 1/1/2015
• Prevention of conversion to abnormal TCD with hydroxyurea in sickle cell anemia: a phase III international randomized clinical trial  
  Hankins JS, McCarville MB, Rankine-Mullings A, Reid ME, Lobo CL, Moura PG, Ali S, Soares D, Aldred K, Jay DW, Aygun B, Bennett J, Kang G, Goldsmith JC, Smeltzer MP, P..., American Journal of Hematology, 1/1/2015
• Provider transition readiness assessment for sickle cell patients: A quality improvement project  
  Porter J, Carroll Y, Anderson S, Lavoie P, Hamilton L, Johnson M, Hankins J, Journal of Clinical Outcomes Management, 1/1/2014
• Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function  
  Brown AO, Mann B, Gao G, Hankins JS, Humann J, Giardina J, Faverio P, Restrepo MI, Halade GV, Mortensen EM, Lindsey MOL, Hanes M, HappelKI, Nelson S, Esteban A, Bagby ..., PLoS Pathog, 1/1/2014
• International survey of T2* cardiovascular magnetic resonance in beta thalassemia major  
  Carpenter J-P, Roughton M, Pennell DJ, and the Myocardial Iron in Thalassemia (MINT) Investigators, Haematologica, 1/1/2013
• Evaluation of Hydration Status, Sodium and Fluid Intake in Children with Sickle Cell Anemia  
  Williams-Hooker R, Ringwald Smith K, Hankins J, Shurley TA, Stockton MB, J Blood Disord Transfus, 1/1/2013
• Automated T2* Measurements Using Supplementary Field Mapping to Assess Cardiac Iron Content  
  Taylor BA, Loeffler RB, Song R, McCarville MB, Hankins JS, Hillenbrand CM, J MagnReson Imaging, 1/1/2013
• Trends in transfusion burden among long-term survivors of childhood hematological malignancies  
  Nottage K, Gurney J, Smeltzer M, Castellanos M, Hudson M, Hankins J, Leuk Lymphoma, 1/1/2013
• Simultaneous Field and R2* Mapping to Quantify Liver Iron Content Using Autoregressive Moving Average Modeling  
  Taylor B, Loeffler RB, Song R, McCarville ME, Hankins JS, Hillenbrand CM, J Magn Reson Imaging, 1/1/2013
• Neurocognitive Screening with Brigance Preschool Screen-II in Three-Year-Old Children with Sickle Cell Disease  
  Aygun B, Parker J, Freeman M, Stephens AL, Smeltzer MP, Wu S, Hankins JS, Wang WC, Pediatr Blood Cancer, 1/1/2011
• 50 Years Ago in the Journal of Pediatric: sudden death during sickle cell anemia crises in young children  
  Hankins JS, J Pediatr, 1/17/2010
• Comparison of whole liver and small region of interest measurements of liver R2* in patients with iron overload  
  McCarville BM, Hillenbrand C, Loeffler RB, Smeltzer MP, Song R, Li C-S, Hankins J, Pediatr Radiol, 1/1/2010
• “It’s our job”: qualitative study of family responses to ableism  
  Neely-Barnes SL, Graff JC, Roberts RJ, Hall HR, Hankins JS, Intellect Dev Disabil, 1/1/2010
• Patterns of liver iron accumulation in sickle cell anaemia and thalassaemia patients with iron overload  
  Hankins JS, Smeltzer MP, McCarville MB, Aygun B, Hillenbrand CM, Ware RE, Onciu M, Eur J Haematol, 1/1/2010
• The painful face of poverty Highlight Editorial  
  Hankins JS, Wang WC, Pediatr Blood Cancer, 1/1/2009
• Join now to see all

Books/Book Chapters

• Wintrobe’s Clinical Hematology 
  Chapter: Sickle cell disease and other sickling syndromes 
  Hankins JS, Wang WCEdition 13th,
• Future Perspectives for the Treatment of Sickle Cell Anemia 
  Chapter: Sickle Cell Anemia: From Basic Science to Clinical Practice 
  Nottage KA, Estepp JH, Hankins JSEdition 1st,

Abstracts/Posters

• Transition Continuity Promotes Long-Term Retention in Adult Care Among Young Adults with Sickle Cell Disease
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Evaluation of Factors Influencing Health Literacy in Adolescents and Adults with Sickle Cell Disease
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Longitudinal Effect of Hydroxyurea Therapy on Left Ventricular Diastolic Function in Sickle Cell Anemia
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Transcranial Doppler Velocities Conversion Rate Based on Increasing Hemoglobin Concentration: Analysis from the SCCRIP Cohort Study
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor
  Jane S. Hankins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Smooth transition from adolescent to adult care in Sickle Cell Disease
  Hankins JS, SINERGe Northeast Regional Sickle Cell Collaborative Monthly Webinar, 1/23/2016
• Sickle cell disease as model for transition from pediatric to adult care
  Hankins JS, Le Bonheur Medical Center Grand Rounds, 1/4/2016
• Expanded use of hydroxyurea in sickle cell disease
  Hankins JS, 10th Annual Sickle Cell in Focus Conference, NHLBI, Bethesda, MA, 1/2/2016
• New therapies for sickle cell disease
  Hankins JS, Grand rounds, Regional Hematology-Oncology Symposium, Our Lady of the Lake Hospital, Baton Rouge, 1/6/2015
• Transition from pediatric to adult care for chronic diseases: sickle cell disease as a model
  Hankins JS, Grand rounds, Regional Hematology-Oncology Symposium, Our Lady of the Lake Hospital, Baton Rouge, 1/6/2015
• Use of mobile health in sickle cell disease
  Hankins JS, VIII National Brazilian Symposium on Sickle Cell Disease, Vitoria, ES, Brazil, 1/5/2015
• Transition from pediatric to adult care among patients with sickle cell disease
  Hankins JS, VIII National Brazilian Symposium on Sickle Cell Disease, Vitoria, ES, Brazil, 1/5/2015
• New therapeutic avenues for sickle cell disease
  Hankins JS, VIII National Brazilian Symposium on Sickle Cell Disease, Vitoria, ES, Brazil, 1/5/2015
• Transition from pediatric to adult care for chronic diseases: sickle cell disease as a model
  Hankins JS, Tennessee State Pediatric Conference, Nashville, TN, 1/20/2014
• Reducing Mortality in SCD
  Hankins JS, Global SCD Network Meeting, Rio de Janeiro, Brazil, 1/1/2014
• Refining MRI Technique for Tissue Assessment of Iron Overload
  Hankins JS, Heme/Onc Research Lecture Series, Baylor College of Medicine, Houston, TX, 1/1/2014
• Refining MRI Technique for Tissue Assessment of Iron Overload
  Hankins JS, Hematology Research Seminar, Cincinnati Children’s Hospital, 1/29/2013
• Chair of workshop session: Defining Successful Transition Practices For Patients with Hemoglobinopathies, Bleeding Disorders And Cancer Survivors
  Hankins JS, American Society of Pediatric Hematology and Oncology Annual meeting, Miami, FL, 1/24/2013
• Multidisciplinary care in SCD: the role of the physician
  Hankins JS, VII Brazilian SCD symposium, Salvador, Bahia, Brazil, 1/22/2013
• Transition to Adult Care in SCD
  Hankins JS, VII Brazilian SCD symposium, Salvador, Bahia, Brazil, 1/21/2013
• Acute Complications in Pediatric SCD
  Hankins JS, VII Brazilian SCD symposium, Salvador, Bahia, Brazil, 1/21/2013
• Building a program for Transition from Pediatric to Adult Care: SCD as a Model
  Hankins JS, Nationwide Children’s Hospital, Friday Hematology/Oncology Seminar, 1/20/2013
• New therapies in sickle cell disease
  Hankins JS, HEMORIO Annual Preceptorship meeting, Rio de Janeiro, Brazil, 1/9/2013
• Join now to see all

Lectures

• Sickle Cell Disease in Young and Old: A Time for Re-Evaluation 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019